Global Neurofibromatosis type-1 Market Restraints
Radiation therapy is conducted for the treatment of neurofibromatosis which leads to damaging of surrounding tissue of targeted tumors, and further leads to damaging of good blood cells. It could affect the process of generating the new generation process of blood cells. Moreover, inability to kill tumor cells which are not able to see in scans is a limitation in radiation therapy. Furthermore, chemotherapy may include late effects such as heart problems and reduced lung capacity. These factors are expected to restrain growth of the global Neurofibromatosis type-1 market.
Neurofibromatosis Type-1 Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients